Results 111 to 120 of about 8,347 (234)

Extracellular vesicle lipidomics liquid biopsy reveals systemic and tumor microenvironment metabolic reprogramming in ovarian cancer

open access: yesMolecular Oncology, EarlyView.
Extracellular vesicle (EV) lipidomic profiling of plasma and ascites from patients with high‐grade serous ovarian cancer and of ovarian cancer cell lines reveals enrichment of triglycerides (TGs), diacylglycerols (DGs), phosphatidylcholine (PCs), sphingomyelins (SMs), reflecting tumor metabolic reprogramming.
Shikha Rani   +9 more
wiley   +1 more source

Prognostics and Health Management Based on Next-Generation Technologies: A Literature Review

open access: yesApplied Sciences
With the rapid development of science and technology, the integration and complexity of aerospace vehicles, weaponry, and large-scale chemical equipment are becoming higher and higher. PHM plays an important role in realizing reductions in equipment loss
Zhou Fang, Wei Li, Liang Su, Jinkui Feng
doaj   +1 more source

Multi-step ahead battery SOC estimation using data-driven prognostics and health management [PDF]

open access: yes
This paper proposes a data-driven multi-step ahead battery state of charge (SOC) forecasting system that can be used for prognostics and health management (PHM) of a battery management system (BMS).
Yu, H., McEwan, A., Pimentel, J.
core   +1 more source

Predictive and prognostic biomarkers of Bacillus Calmette‐Guérin therapy failure in bladder cancer patients: A systematic review

open access: yesMolecular Oncology, EarlyView.
High‐risk bladder cancer is typically treated with Bacillus Calmette‐Guérin (BCG), but 30–40% of patients relapse. No FDA‐ or CE‐approved biomarkers currently predict or prognosticate BCG failure. We systematically reviewed the literature and identified 72 eligible studies, revealing several promising biomarkers associated with BCG treatment response ...
Rui Ribeiro‐Pereira   +7 more
wiley   +1 more source

Large Language Model-Based Autonomous Agent for Prognostics and Health Management

open access: yesMachines
Prognostics and Health Management (PHM), including fault diagnosis and Remaining Useful Life (RUL) prediction, is critical for ensuring the reliability and efficiency of industrial equipment. However, traditional AI-based methods require extensive expert
Minhyeok Cha   +6 more
doaj   +1 more source

Unique circulating miRNAome signatures captured with distinct molecular states in Lynch syndrome and sporadic colorectal cancer

open access: yesMolecular Oncology, EarlyView.
Circulating microRNA profiles distinguish nonmalignant Lynch syndrome from cancer‐associated Lynch syndrome, sporadic colorectal cancer, and healthy controls. Age‐stratified analysis reveals disease‐specific regulatory states, and a six‐miRNA panel shows concordant separation in an independent colorectal tissue cohort.
Ramadhani Salum Chambuso   +5 more
wiley   +1 more source

SPHINX31 acts as a SRPK1 inhibitor targeting the ATR/DNA‐PKcs/CHK1 replicative checkpoint to inhibit cell growth in non‐small cell lung cancer

open access: yesMolecular Oncology, EarlyView.
The kinase SRPK1 directly interacts with the protein TOPBP1 and regulates the pre‐mRNA splicing of WIZ thereby contributing to the activation of the ATR/CHK1 replicative checkpoint in response to replicative stress. This allows cancer cells' genomic stability and survival.
Amani Shreim   +17 more
wiley   +1 more source

Digital Twin Generalization with Meta and Geometric Deep Learning

open access: yes
Deep digital twins (DDTs) are deep neural networks that encode the behavior of complex physical systems. DDTs are excellent system representations due to their ability to continuously adapt to operational changes and their capability to capture complex ...
Fink, Olga, Theiler, Raffael
core   +1 more source

Characterization of therapeutic antibodies targeting lymphatic and vascular resistance factor for the treatment of hypervascularized and highly metastatic cancers

open access: yesMolecular Oncology, EarlyView.
LVRF (lymphatic and vascular resistance factor) is a VEGFA splice variant upregulated in response to anti‐angiogenic therapy that fosters tumor adaptation through enhanced vascularization, lymphangiogenesis, and metastatic dissemination. Targeting LVRF with fully human neutralizing antibodies disrupts these processes and limits resistant tumor growth ...
Marion David   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy